FinHisaab LogoFinHisaab

Command Palette

Search for a command to run...

BFBIO · BF Biosciences Limited

Board Meeting

Filed
21 September 2026 at 11:05 am
Category
Meetings
Sentiment
Neutral
Impact
Low

AI executive summary

BF Biosciences Limited has announced that a meeting of its Board of Directors will be held on September 28, 2026, to consider the annual financial results for the period ended June 30, 2026, and potential entitlements. A closed period has been declared from September 21, 2026, to September 28, 2026.

Key takeaways

  • Board meeting scheduled for September 28, 2026
  • To review annual financial results for the period ended June 30, 2026
  • Closed period in effect from September 21 to September 28, 2026

Filing details

Board meeting

Status
Scheduled
Meeting date
28 September 2026 at 5:00 pm
Purpose
To consider annual financial results and declaration of any entitlement
Closed period
21 September 2026 – 28 September 2026
  • Consider the Annual Financial Results for the period ended 2026-06-30
  • Declaration of any entitlement
  • #board meeting
  • #financial results
  • #annual results
  • #closed period

This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.